Expression of concern
p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes
Paper Information
Record ID:
38658
Publication Date:
February 15, 2009
Retraction Date:
August 22, 2022
(3.2 years years ago)
Subjects:
Institutions:
- Program in Molecular and Cellular Biology, School of Graduate Studies, SUNY Downstate Medical Center, Brooklyn, New York 11203
- Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065
- Departments of Pediatrics and Anatomy and Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York 11203
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Microbiology
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1128/mcb.00324-22Citations (112)
112
Total Citations15
Post-Retraction(13.4%)
97
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
10
Within 1 year
4
After 2+ years
984
Days since retraction (latest)
Bioactive compound combinations from Rhodiola tangutica alleviate pulmonary vascular remodeling in high-altitude pulmonary hypertension rats through the PI3K–AKT pathway
Na Yang, Meiduo Huayu, Shanshan Su et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: May 2025
984 days after retraction
Inhibition of IKK complex by (2 methyl butyryl) Shikonin, a naturally occurring naphthoquinone, abrogates melanoma growth and progression via modulation of the IKK/NFκB /EMT signaling axis
Aalim Maqsood Bhat, Irshad Ahmad Bhat, Minnie Malik et al. (8 authors)
International Immunopharmacology
Published: Jan 2025
1 citation
1 citation
880 days after retraction
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma
Zizhou Niu, Zhichao Shi, Guoxiang Wu et al. (21 authors)
Bioorganic Chemistry
Published: Dec 2024
1 citation
1 citation
851 days after retraction
In silico identification of novel CDK4 inhibitors for retinoblastoma.
Mukesh Kumar, V. C. Srivastava, Uma Devi et al. (6 authors)
Chemical Physics Impact
Open Access
Published: Sep 2024
5 citations
5 citations
741 days after retraction
A molecular landscape of quiescence and proliferation highlights the role of Pten in mammary gland acinogenesis
Rebeka Tomasin, Ana Maria Rodrigues, Antonio Carlos Manucci et al. (4 authors)
Journal of Cell Science
Open Access
Published: Sep 2023
5 citations
5 citations
389 days after retraction
FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth
Miao Yu, Weijie Wu, Yi Sun et al. (15 authors)
Cell Reports
Open Access
Published: Jul 2023
12 citations
12 citations
343 days after retraction
EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27Kip1
Fragka Pegka, Nathalie Ben‐Califa, Drorit Neumann et al. (5 authors)
Cells
Open Access
Published: Jun 2023
4 citations
4 citations
305 days after retraction
Janus Kinase 3 phosphorylation and the JAK/STAT pathway are positively modulated by follicle-stimulating hormone (FSH) in bovine granulosa cells
Amir Zareifard, Francis Beaudry, Kalidou Ndiaye
BMC Molecular and Cell Biology
Open Access
Published: Jun 2023
7 citations
7 citations
302 days after retraction
Pten is a disconnecting node in the molecular landscape of the proliferation/quiescence decision during mammary gland acinogenesis
Rebeka Tomasin, Ana Maria Rodrigues, Antonio Carlos Manucci et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2023
204 days after retraction
Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm
Suman Saurabh, Karthik Nadendla, Shubh Sanket Purohit et al. (5 authors)
ACS Omega
Open Access
Published: Mar 2023
38 citations
38 citations
198 days after retraction
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Tatjana Arsenijevic, Katia Coulonval, Eric Raspé et al. (6 authors)
Cancers
Open Access
Published: Feb 2023
9 citations
9 citations
165 days after retraction
Epibrassinolide impaired colon tumor progression and induced autophagy in SCID mouse xenograft model via acting on cell cycle progression without affecting endoplasmic reticulum stress observed in vitro
Pınar Obakan Yerlikaya, Kaan Adacan, Ayşe Karatuğ Kaçar et al. (5 authors)
The International Journal of Biochemistry & Cell Biology
Open Access
Published: Dec 2022
2 citations
2 citations
129 days after retraction
Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Sathyen A. Prabhu, Omar Moussa, Christophe Gonçalves et al. (23 authors)
Molecular Cancer Therapeutics
Open Access
Published: Dec 2022
5 citations
5 citations
109 days after retraction
Endothelial cell cycle state determines propensity for arterial-venous fate
Nicholas W. Chavkin, Gaël Genet, Mathilde Poulet et al. (16 authors)
Nature Communications
Open Access
Published: Oct 2022
59 citations
59 citations
45 days after retraction
PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation
Changze Song, Jianong Zhang, Xiao Liu et al. (12 authors)
Frontiers in Oncology
Open Access
Published: Sep 2022
17 citations
17 citations
36 days after retraction
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi et al. (7 authors)
International Journal of Biological Macromolecules
Published: Jul 2022
28 citations
28 citations
30 days before retraction
Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation
Jacob B. Swadling, Tobias Warnecke, Kyle L. Morris et al. (4 authors)
Biophysical Journal
Open Access
Published: May 2022
13 citations
13 citations
89 days before retraction
Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression
Heidelinde Jäkel, Martin Taschler, Karin Jung et al. (10 authors)
Leukemia
Open Access
Published: May 2022
3 citations
3 citations
93 days before retraction
Janus Kinase 3 phosphorylation and the JAK/STAT pathway are positively modulated by follicle-stimulating hormone (FSH) in bovine granulosa cells
Amir Zareifard, Francis Beaudry, Kalidou Ndiaye
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2022
197 days before retraction
CDK4 and CDK6 kinases: From basic science to cancer therapy
Anne Fassl, Yan Geng, Piotr Siciński
Science
Open Access
Published: Jan 2022
329 citations
329 citations
220 days before retraction
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
Yong Weon Yi, Kyu Sic You, Jeong‐Soo Park et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2021
76 citations
76 citations
244 days before retraction
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27
Katia Coulonval, Vincent Vercruysse, Sabine Paternot et al. (7 authors)
Cell Cycle
Open Access
Published: Dec 2021
10 citations
10 citations
249 days before retraction
Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
Betheney R. Pennycook, Alexis R. Barr
Open Biology
Open Access
Published: Nov 2021
40 citations
40 citations
294 days before retraction
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
Gian Luca Rampioni Vinciguerra, Alessandra Dall’Acqua, Ilenia Segatto et al. (14 authors)
Cell Death and Disease
Open Access
Published: Oct 2021
10 citations
10 citations
311 days before retraction
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
Irina Jilishitz, Jason Luis Quiñones, Priyank Patel et al. (14 authors)
Molecular Cancer Research
Open Access
Published: Aug 2021
7 citations
7 citations
361 days before retraction
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Ni Made Pitri Susanti, Daryono Hadi Tjahjono
Molecules
Open Access
Published: Jul 2021
32 citations
32 citations
394 days before retraction
Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα
Kyung‐Hwa Jeon, Aarajana Shrestha, Hae Jin Jang et al. (8 authors)
Biomolecules & Therapeutics
Open Access
Published: May 2021
3 citations
3 citations
459 days before retraction
Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
Betheney R. Pennycook, Alexis R. Barr
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2021
1 citation
1 citation
472 days before retraction
Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation
Jacob B. Swadling, Tobias Warnecke, Kyle L. Morris et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
2 citations
2 citations
564 days before retraction
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells
Tijs Merckaert, Olivier Zwaenepoel, Kris Gevaert et al. (4 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Dec 2020
15 citations
15 citations
623 days before retraction
A unified model for the G1/S cell cycle transition
Samuel Hume, Grigory L. Dianov, Kristijan Ramadan
Nucleic Acids Research
Open Access
Published: Oct 2020
150 citations
150 citations
677 days before retraction
Endothelial Cell Cycle State Determines Propensity for Arterial-Venous Fate
Nicholas W. Chavkin, Gaël Genet, Mathilde Poulet et al. (12 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2020
6 citations
6 citations
740 days before retraction
Ubiquitin–proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Chenxi Zhao, Chenming Zeng, Ke Wang et al. (7 authors)
Acta Pharmacologica Sinica
Open Access
Published: Jun 2020
15 citations
15 citations
784 days before retraction
AMPKα2 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation
Hailong Wang, Fuqin Tang, Yunhan Jiang et al. (6 authors)
Journal of Physiology and Biochemistry
Published: Jun 2020
14 citations
14 citations
789 days before retraction
Restriction point regulation at the crossroads between quiescence and cell proliferation
Betheney R. Pennycook, Alexis R. Barr
FEBS Letters
Open Access
Published: Jun 2020
68 citations
68 citations
792 days before retraction
The Kinase-Dependent and Independent Functions of Cdk4 and Cdk6 Regulate Continuous Proliferation and the Exit From Quiescence Differently
Sarah Nataraj, Stacy W. Blain
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2020
2 citations
2 citations
850 days before retraction
Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity
Mahdieh Mehrpouri, Ava Safaroghli‐Azar, Atieh Pourbagheri‐Sigaroodi et al. (5 authors)
European Journal of Pharmacology
Published: Mar 2020
27 citations
27 citations
902 days before retraction
An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: <i>Diagnostic and therapeutic implications</i>
Asish Dasgupta, Kuang‐Hueih Chen, Danchen Wu et al. (17 authors)
The FASEB Journal
Published: Feb 2020
21 citations
21 citations
916 days before retraction
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Keelan Z. Guiley, Jack W. Stevenson, Kevin Lou et al. (12 authors)
Science
Open Access
Published: Dec 2019
198 citations
198 citations
983 days before retraction
Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach
Anukriti Anukriti, Anupam Dhasmana, Swati Uniyal et al. (11 authors)
Genes
Open Access
Published: Jul 2019
8 citations
8 citations
1123 days before retraction
In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours
Alexandra Schoos, Vanessa M. Knab, Cordula Gabriel et al. (8 authors)
Veterinary and Comparative Oncology
Published: Jun 2019
10 citations
10 citations
1162 days before retraction
Advanced oxidation protein products induce G1 phase arrest in intestinal epithelial cells via a RAGE/CD36-JNK-p27kip1 mediated pathway
Jie Shi, Shibo Sun, Yan Liao et al. (11 authors)
Redox Biology
Open Access
Published: Apr 2019
23 citations
23 citations
1223 days before retraction
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Lucía García-Gutiérrez, M. Dolores Delgado, Javier León
Genes
Open Access
Published: Mar 2019
202 citations
202 citations
1249 days before retraction
Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma
Juan Liu, Li Min, Shengtao Zhu et al. (9 authors)
Journal of Cancer
Open Access
Published: Jan 2019
24 citations
24 citations
1329 days before retraction
MicroRNA‐221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27
Xiaohui Hu, Zexue Zhao, Jian Dai et al. (5 authors)
Journal of Cellular Biochemistry
Published: Dec 2018
36 citations
36 citations
1338 days before retraction
Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma
Afak Rasheed Salman Zaidi, Sadie Dresman, Charlotte Burt et al. (5 authors)
Journal of Cell Communication and Signaling
Open Access
Published: Nov 2018
5 citations
5 citations
1370 days before retraction
A BAP31 intrabody induces gastric cancer cell death by inhibiting p27 <sup>kip1</sup> proteasome degradation
Jing Chen, Haotian Guo, Haitao Jiang et al. (8 authors)
International Journal of Cancer
Open Access
Published: Oct 2018
36 citations
36 citations
1403 days before retraction
MicroRNA‐133b suppresses bladder cancer malignancy by targeting TAGLN2‐mediated cell cycle
Feng Zhao, Liuhua Zhou, Yu‐Zheng Ge et al. (9 authors)
Journal of Cellular Physiology
Published: Oct 2018
27 citations
27 citations
1408 days before retraction
Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers
Joel D. Maust, Christy L. Frankowski-McGregor, Armand Bankhead et al. (5 authors)
Molecular Cancer Therapeutics
Open Access
Published: Sep 2018
12 citations
12 citations
1427 days before retraction
Structural insights into the functional diversity of the CDK–cyclin family
D.J. Wood, Jane Endicott
Open Biology
Open Access
Published: Sep 2018
227 citations
227 citations
1451 days before retraction
Quick Stats
Total Citations:
112
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025